首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

2056542

支氣管擴張劑市場規模、佔有率、趨勢和預測：按適應症、藥物類型、給藥途徑和地區分類（2026-2034 年）

Bronchodilators Market Size, Share, Trends and Forecast by Indication, Drug Type, Route of Administration, and Region 2026-2034

出版日期: 2026年06月01日 | 出版商:

IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球支氣管擴張劑市場預計在2025年達到408.9億美元，到2034年將達到587.3億美元，2026年至2034年的複合年成長率（CAGR）為3.98%。推動該市場成長的主要因素包括氣喘和慢性阻塞性肺病（COPD）等呼吸系統疾病盛行率的上升、吸入療法的認知度和使用率的提高以及全球醫療保健支出的成長。 2023年，全球約有3.63億人患有氣喘，導致約44.2萬人死亡。如此高的盛行率和沈重的死亡負擔推動了對支氣管擴張劑的需求，因為這些藥物對於控制氣喘症狀、改善呼吸功能和預防嚴重急性發作至關重要。氣喘佔了最大的市場佔有率，達到52.6%。吸入器是主要的給藥方式，佔61.8%。北美佔全球市場佔有率的37.9%。

支氣管擴張劑是用於治療長期氣道狹窄和發炎性疾病的藥物，例如氣喘、肺氣腫和慢性阻塞性肺病（COPD）。它們透過放鬆氣道和支氣管周圍的肌肉、清除肺部粘液並使呼吸更順暢來幫助緩解相關症狀。支氣管擴張劑有多種劑型，包括片劑、液體、霧化溶液、定量噴霧吸入器和乾粉吸入器。目前，支氣管擴張劑也用於增強吸入性皮質類固醇的療效，而吸入性皮質類固醇是減輕發炎和預防氣喘發作的主要治療方法。

支氣管擴張劑市場趨勢：

新冠肺炎疫情導致急性呼吸道感染疾病患者數量顯著增加，這是影響全球支氣管擴張劑需求的主要因素之一。此外，空氣感染疾病加劇、吸菸人數上升以及感染疾病在全球蔓延，都增加了肺部疾病的風險，這也是推動市場成長的另一個因素。肺功能會隨著老齡化成長而逐漸下降，這會導致呼吸困難。此外，老年人口的成長和消費者購買力的顯著提高也是推動市場成長的因素。醫療基礎設施和診斷方法的改進以及向非侵入性治療的轉變等因素也在促進市場成長。此外，目前有幾種新型支氣管擴張劑正處於臨床前階段，這些藥物有望克服現有產品的限制。同時，許多國家的衛生組織正在支持支氣管擴張劑的研發活動，預計將為市場帶來良好的前景。

本報告解答的主要問題

全球支氣管擴張劑市場規模有多大？
2026年至2034年全球支氣管擴張劑市場的預期成長率為何？
推動全球支氣管擴張劑市場發展的主要因素是什麼？
新冠疫情對全球支氣管擴張劑市場產生了哪些影響？
全球支氣管擴張劑市場依適應症分類的結構是怎樣的？
全球支氣管擴張劑市場按藥物類型分類的組成是什麼？
全球支氣管擴張劑市場依給藥途徑分類的組成是什麼？
全球支氣管擴張劑市場的主要地區有哪些？
全球支氣管擴張劑市場的主要參與者有哪些？

The global bronchodilators market reached USD 40.89 Billion in 2025 and is projected to reach USD 58.73 Billion by 2034, growing at a CAGR of 3.98% during 2026-2034. The market is driven by the rising prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), alongside growing awareness and adoption of inhalation therapies and increasing healthcare expenditure worldwide. In 2023, around 363 million individuals worldwide were affected by asthma, resulting in approximately 442,000 fatalities. This high prevalence and significant mortality burden are fueling the demand for bronchodilators, as these medications are essential for managing asthma symptoms, improving respiratory function, and preventing severe exacerbations. Asthma dominates at 52.6%. Inhaler leads the route of administration at 61.8%. North America commands 37.9% of the global market share.

Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. They are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.

Bronchodilators Market Trends:

A significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions. This is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market. Other factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on indication, drug type and route of administration.

Breakup by Indication:

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Others

Breakup by Drug Type:

Sympathomimetics
Anticholinergics
Phosphodiesterase Inhibitor
Combination Drugs

Breakup by Route of Administration:

Oral
Injection
Inhaler

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

1.How big is the global bronchodilators market?
2.What is the expected growth rate of the global bronchodilators market during 2026-2034?
3.What are the key factors driving the global bronchodilators market?
4.What has been the impact of COVID-19 on the global bronchodilators market?
5.What is the breakup of the global bronchodilators market based on the indication?
6.What is the breakup of the global bronchodilators market based on the drug type?
7.What is the breakup of the global bronchodilators market based on the route of administration?
8.What are the key regions in the global bronchodilators market?
9.Who are the key players/companies in the global bronchodilators market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Bronchodilators Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Indication

6.1 Asthma
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Chronic Obstructive Pulmonary Disease (COPD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Sympathomimetics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Anticholinergics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Phosphodiesterase Inhibitor
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Combination Drugs
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Injection
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Inhaler
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 GSK plc

簡介目錄圖表

List of Figures

Figure 1: Global: Bronchodilators Market: Sales Value (in Billion USD), 2020-2025
Figure 2: Global: Bronchodilators Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 3: Global: Bronchodilators Market: Breakup by Indication (in %), 2025
Figure 4: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2025
Figure 5: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2025
Figure 6: Global: Bronchodilators Market: Breakup by Region (in %), 2025
Figure 7: Global: Bronchodilators (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Bronchodilators (Oral) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Bronchodilators (Injection) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: North America: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: North America: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: United States: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: United States: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Canada: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Canada: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Asia-Pacific: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: China: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: China: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Japan: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Japan: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: India: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: India: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: South Korea: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: South Korea: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Australia: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Australia: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Indonesia: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Others: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Others: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Europe: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Europe: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Germany: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Germany: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: France: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: France: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: United Kingdom: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Italy: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Italy: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Spain: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Spain: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Russia: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Russia: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Others: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Others: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Latin America: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Latin America: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: Brazil: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: Brazil: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: Mexico: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: Mexico: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Others: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Others: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Middle East and Africa: Bronchodilators Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2025
Figure 75: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 76: Global: Bronchodilators Industry: SWOT Analysis
Figure 77: Global: Bronchodilators Industry: Value Chain Analysis
Figure 78: Global: Bronchodilators Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million USD), 2026-2034
Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million USD), 2026-2034
Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Bronchodilators Market: Competitive Structure
Table 7: Global: Bronchodilators Market: Key Players

02-2729-4219

+886-2-2729-4219